Chinesestuff4
From SusoSight
* Pinnacle Partners * EB-5 / Regional Center * IP / Technology Transfer * Tech Investment Fund * Products * Contact Us
Home IP / Technology Transfer PDF Print E-mail
这些独特的技术产品，
即拥有完整的知识产权保护，又有生产厂家的支持服务。我们为您提供中英文版本的介绍草案,中文部分请向下拖拉。
Technology licensing and IP rights Transfer Offer
The offer of these exclusive technology products featuring complete I.P. protection and producer support, are offered in English and Chinese. For Chinese please scroll down the page.
技术许可证和知识产权转让方案
尖峰国际股份有限公司简介
尖峰国际股份有限公司，在美国和中国均设立机构，旨在向美国本土以外的、经甄选的买家销售和准许技术产品。尖峰公司与专门的政府机构及拥有专利的公司一起工作，为其销售或安排这些知识产权的合作伙伴关系。
专利转让、政府许可协议以及投资者的资金将投入到医疗设备和药品市场上。同时，我们拥有其它象媒介这样专业领域的代理许可。
尖峰公司已获得其客户授予的代理权，为其安排技术销售、特许分销、发展产品生产的合作伙伴、
安排专利转让，并和有兴趣引进这些享有专利权及证照的独特产品的公司，发展互利的合作关系。
私募发售
我们许多客户向那些对持有独特专利公司感兴趣的亚洲公司提供投资咨询。这些公司希望进一步发展他们的产品线、新一代产品的生产新技术和研发方案。
诚邀阁下浏览我们为您展示的每一个产品的简单介绍。我们将根据您的具体要求，为您提供进一步的信息。PPM – 私募备忘录将按您的要求提供。
我们的技术产品可被视作可能的收购对象、镶金的投资机会、知识产权的购买、在中国合资生产。
如您对上述任何一个方案感兴趣，请按以下方式联系我们：
尖峰技术股份有限公司
沃尔那特北大街520号
印弟安那州布卢明顿市
邮编：47404
请洽：谢凯文 先生 / Kevin Jeffers
中国资产管理部 副总裁
电话：(812) 606-1550
传真：(812) 335-1961
信箱地址：
印弟安那州布卢明顿市
1772信箱
邮编：47402 现有技术
组织再生和创伤溃疡 ( add link to "Tissue regeneration from ulcers and wounds " page
美国设计与工艺专利，已通过美国食品和药物管理局第一和第二阶段临床试验，第三阶段正在完成最后20项临床试验
产品
- 随着糖尿病相关性溃疡创面和创伤的增加，从烧伤创面、事故、疾病和相关领域，在美国和欧共体中，组织再生品已是一个快速成长的市场
- 角质形成细胞是伤口愈合的要素，如伤口区域的生长因子和细胞因子
- Delnet面料为伤口提供清创功能
- 微载体珠帮助捕获细胞成分，如细胞溶解产物
应用
烧伤领域
+皮肤移植供体网站
+偏度烧伤创面
+深Ⅱ度烧伤创面
+肥厚性疤痕+
+其他皮肤疾病，如表皮Bulosa
手术创面
+去除（一直到真皮深层的文身）
+截肢残端
+创伤伤口（军事）
+疤痕的修复
+瘢痕疙瘩去除
（详细的产品和技术信息见附件或网站链接:----------- 请选择）
股骨导管插入仪 ( add link to "Femoral catheterization device" page
美国设计和工艺专利和批准，获美国食品和药物管理局批准，进入销售市场，目前主要销售对象为在美国本土开业的医生
产品
美国FDA（食品和药物管理局）批准并授予预置生物闭合（小肠黏膜下层，简称："SIS"）介入式套管专利。该仪器用于导管插入术后，密闭股动脉的治疗。
认证
早在2007年8月，该装置即获得FDA的上市前许可（PMA）。 2008年7月，美国食品药品管理局清理了美国市场上在售的日益增多的式样繁复的产品。本产品在功效和销售领域均超越其他产品，成为当前市场中的佼佼者。
可再吸收的栓塞专利
该产品独特在于，动脉穿刺部位，用获专利的生物可再吸收的细胞外基质（ECM）填补。ECM，也就小肠黏膜下层（SIS），这项独特的、经临床验证的生物材料专利技术，可进入血管壁将其百分百重塑。就目前动脉切开术，或将异物留在血管穿刺部位来讲，是巨大进步。
（详细的产品和技术信息见附件或网站链接:----------- 请选择）
外携式可调节药物剂量治疗仪 ( add link to "External medication device with flow regulator" page )
美国设计专利获得批准，美国食品和药物管理局批准进入销售和市场营销，目前主要销售对象为在美国本土开业的医生
产品
本产品是一种一次性人造橡胶机械泵，装置内注入局部麻醉剂，与外科医生和麻醉师提供的控制药物一并使用。将该装置连接到一个导管，放置在手术切口或 接近手术切口的地方，控制流入导管的局部麻醉剂量。手术后，患者可佩带此装置，回家后可移除或丢弃。这个装置和局部麻醉剂有效地控制了患者的疼痛感，并且 减少甚至消除患者对全身麻醉的需要。
专利
- 本公司拥有的第一代产品线的II类510k产品。由于美国FDA正在加强对这类装置的监管要求，510k的价格正在上升。
- 在2010年第四季度，生产商将向市场推出第二代II类510k产品。
- 本公司已成功地通过2009年美国FDA生产作业检查。
（详细的产品和技术信息见附件或网站链接:-----------请选择）
Introducing Pinnacle International
Pinnacle International LLC, with offices in the U.S. and China, specializes in the sale and licensing of technology products to select buyers outside of the U.S. Pinnacle works with companies who hold patents and unique government and would like to sell or arrange partnerships with these IP properties.
Patents transfers, government licensing agreements and well as investor funding are in the medical device and pharmaceutical market. We also hold licensing agencies for other more specialized markets in media technologies.
Pinnacle has been granted agent rights by its’ clients to arrange the sale of technology, license distribution, partner in product production, arrange patent transfers, and develop other advantageous relationships for companies interested in the import of these unique products covered by Intellectual Property rights and licensing.
Private Placement Offer
Many of our clients are also make inquiries for investments by Asian companies interested in partnering with a company holding unique patents and licensing. These companies want to further develop their product lines, produce new technologies and research options in next generation products.
We invite you to review the outline for each of the products we represent. Additional information is available as needed. PPM - Private Placement Memorandum is available on request.
Our technology offerings are to be considered as possible acquisition candidates, gold plated investment opportunities, purchase of intellectual property, joint venturing of production in China.
If you are interested in one of these product offerings, contact us at the following address:
Pinnacle Technology LLC
520 North Walnut Street
Bloomington Indiana 47404
Attention: Kevin Jeffers
Vice President Asset Management / China
Phone number: (812) 606-1550
Fax number: (812) 335-1961
Mailing address:
P.O. Box 1772
Bloomington, In 47402
Available Technology:
Tissue regeneration from ulcers and wounds, click here for more details.
U.S. Design and Process Patented, USA Food and Drug Administration Phase I and II, Phase III pending final 20 clinical trials
Product
- Tissue regeneration product is a fast growing market segment in the USA and EU. With the increase in diabetic related ulcer wounds and wounds from burns, accidents, diseases and conflict zones.
- Keratinocytes provides wound healing factors such as growth factors and cytokines to wound site
- Delnet fabric serves a wound debriding function
- Micro-carrier beads trap cellular components such as cell lysates
Usage:
Burn Market
o Skin Graft Donor Sites
o Partial Thickness Burn Wounds
o Deep Second Degree Burn Wounds
o Hyper tropic Scarring
o Other Skin Disorders such as Epidermal Bulosa
o Surgical Wounds
o Removal of Tattoos (down to deep dermis)
o Amputation Stump
o Trauma Wounds (Military)
o Scar Revisions
o Keloid Removal
(Detailed product and technology information attached or see website link – select here)
Femoral catheterization device click here for more details.
U.S. Design and Process Patented and approved, U.S.A. Food and Drug Administration approved for sales and marketing, now sold to doctors practicing in the U.S.
Product
FDA (Food and Drug Administration) approved and Patented introducer sheath with a proprietary pre-mounted biologic closure (Small Intestinal Submucosa, "SIS"). The device is used to therapeutically seal the femoral artery following a catheterization procedure.
Approvals
The device received Premarket Approval (PMA) from the FDA in August 2007. In July 2008, the FDA cleared the product for sale in the United States with multiple design enhancements. The product is now becoming a leader in the marketplace surpassing other products in efficacy and sales.
Patented reabsorbable Plug
The Product is unique in its placement of a patented bio-resorbable extracellular matrix (ECM) at the site of the arterial puncture. This ECM, also known as small intestinal submucosal (SIS), is a patented, proprietary, clinically proven biologic material that is capable of completely remodeling into the arterial wall. This is a great advance from current devices that leave foreign material at the vascular puncture site, or arteriotomy.
External medication device with flow regulator, click here for more details.
U.S. Design Patent approved, U.S.A. Food and Drug Administration approved for sales and marketing, now sold to doctors practicing in the U.S.
Product
The product is a disposable elastomeric, mechanical pump devices filled with a local anesthetic and with controlled medication delivery by surgeons and anesthesiologists. The device is attached to a catheter that is placed into or near the surgical incision and it controls the flow of the local anesthetic into the catheter. The patient wears the filled device after surgery and takes it home with them where it can be removed and disposed. The device and the local anesthetic control the patient's pain effectively and it reduces or eliminates the need for the patient to take systemic narcotics.
Patents
- The Company has an existing Class II 510k for its first generation product line. The value of this 510k has recently increased as the FDA has tightened its regulatory requirements for these types of devices.
- The Producer will be applying for a Class II 510k on its second generation device in 4th quarter of 2010. - The Company has successfully passed a 2009 FDA inspection of its manufacturing operations
Pinnacle International LLC., Powered by Forte Web Works, LLC Valid XHTML and CSS.